Immutep (IMMP) Debt Ratio (2014 - 2015)
Immutep's (IMMP) quarterly Debt Ratio came in at 0.05 in Q2 2015, down 100.0% on a QoQ basis from 72068.18 in Q4 2014.
Immutep (IMMP) Debt Ratio (2014 - 2015) Analysis & Trends
Immutep (IMMP) has 2 years of Debt Ratio data on file, last reported at 0.05 in Q2 2015.
- Quarterly Debt Ratio changed N/A year-over-year to 0.05 in Q2 2015, while the trailing twelve-month figure through Jun 2015 was 0.05 (changed N/A YoY) and the FY2015 annual result came in at 0.05, changed N/A from the prior year.
- Debt Ratio slipped to 0.05 in Q2 2015, from 72068.18 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 72068.18 in Q4 2014 to a low of 0.05 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | 0.47 |
| 10 | Immutep | 56.94 Mn | -8.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 0.05 |
| Dec 31, 2014 | 72,068.18 |